CN Stock MarketDetailed Quotes

000597 Northeast Pharmaceutical Group

Watchlist
  • 4.52
  • -0.16-3.42%
Market Closed Oct 11 15:00 CST
6.46BMarket Cap16.99P/E (TTM)

Northeast Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
-7.50%4.17B
-17.58%1.94B
-6.42%8.24B
-2.52%6.4B
1.95%4.51B
0.02%2.35B
8.15%8.81B
7.60%6.57B
10.23%4.42B
16.49%2.35B
Operating revenue
-7.50%4.17B
-17.58%1.94B
-6.42%8.24B
-2.52%6.4B
1.95%4.51B
0.02%2.35B
8.15%8.81B
7.60%6.57B
10.23%4.42B
16.49%2.35B
Other operating revenue
-43.47%16.59M
----
-34.58%58.56M
----
7.31%29.36M
----
-9.32%89.5M
----
-33.83%27.36M
----
Total operating cost
-8.67%3.88B
-18.64%1.82B
-9.14%7.66B
-3.92%6.03B
0.95%4.25B
-0.78%2.24B
5.83%8.44B
4.09%6.27B
7.69%4.21B
15.47%2.25B
Operating cost
4.69%2.69B
-9.10%1.2B
-9.06%4.89B
-6.16%3.78B
-5.23%2.57B
-8.33%1.32B
9.10%5.38B
8.49%4.03B
12.68%2.71B
20.38%1.44B
Operating tax surcharges
-17.44%35.59M
-19.35%17.67M
-1.66%81.75M
0.64%61.88M
4.34%43.1M
6.72%21.91M
-0.88%83.13M
-5.84%61.49M
-1.86%41.31M
-4.39%20.53M
Operating expense
-34.77%723.18M
-33.89%386.75M
-11.76%1.81B
-0.72%1.48B
12.38%1.11B
9.82%585.04M
1.72%2.05B
-0.10%1.49B
-0.42%986.54M
7.30%532.71M
Administration expense
-24.86%422.33M
-33.67%204.15M
7.92%815.55M
11.19%708.52M
28.90%562.04M
32.06%307.76M
1.75%755.71M
1.13%637.2M
11.22%436.03M
12.62%233.05M
Financial expense
55.98%-25.48M
46.68%-5.84M
-478.84%-29.97M
-774.81%-50.08M
-1,152.19%-57.9M
-263.89%-10.95M
-93.13%7.91M
-106.54%-5.72M
-108.03%-4.62M
-66.07%6.68M
-Interest expense (Financial expense)
-10.79%35.97M
-8.57%17.9M
-15.98%77.39M
-16.81%56.7M
-8.77%40.32M
-12.66%19.57M
-23.34%92.11M
-23.75%68.15M
-27.59%44.2M
-17.96%22.41M
-Interest Income (Financial expense)
23.53%-77.18M
32.17%-25.69M
-65.18%-155.08M
-82.97%-123.52M
-130.11%-100.93M
-91.35%-37.87M
-67.88%-93.88M
-142.07%-67.51M
-125.08%-43.86M
-103.05%-19.79M
Research and development
44.02%35.98M
34.34%17.04M
-39.50%97.04M
-25.31%42.26M
-36.95%24.98M
-40.05%12.68M
92.18%160.39M
66.37%56.58M
87.90%39.63M
86.29%21.15M
Credit Impairment Loss
-413.52%-2.98M
138.62%257.5K
132.47%6.79M
137.78%2.96M
109.95%952.08K
83.26%-666.68K
-31.24%-20.9M
-453.54%-7.84M
-440.53%-9.57M
-109.24%-3.98M
Asset Impairment Loss
47.46%-66.27M
-11.76%-37.67M
-30.54%-193.49M
-27.15%-138.66M
-57.42%-126.12M
-22.91%-33.7M
-55.39%-148.23M
-142.15%-109.06M
-108.92%-80.11M
-92.94%-27.42M
Other net revenue
88.28%-7.56M
68.83%-3.51M
-124.99%-80.67M
8.14%-64.72M
-0.41%-64.47M
26.56%-11.26M
2,437.36%322.84M
-4,935.75%-70.46M
-500.50%-64.21M
-150.28%-15.33M
Invest income
-61.52%2.93M
--2.27M
--8.61M
--8.29M
--7.62M
----
----
--0
----
----
Asset deal income
-96.17%6.65K
-90.86%6.65K
-99.96%172.21K
500.58%172.91K
328.89%173.92K
79.48%72.78K
12,641.67%419.3M
-101.96%-43.16K
1,263.60%40.55K
1,279.75%40.55K
Other revenue
11.08%58.75M
37.26%31.62M
33.84%97.26M
34.49%62.51M
107.98%52.9M
43.71%23.04M
9.40%72.67M
18.51%46.48M
2.38%25.43M
60.52%16.03M
Operating profit
46.05%278.3M
10.06%117.67M
-28.45%498.23M
37.80%313.74M
31.77%190.56M
26.22%106.92M
271.69%696.36M
188.73%227.67M
63.51%144.61M
35.43%84.71M
Add:Non operating Income
-52.26%3.83M
-68.65%2.36M
-4.71%28.99M
-25.24%15.09M
-50.02%8.02M
260.63%7.54M
344.36%30.43M
436.46%20.18M
551.38%16.04M
317.60%2.09M
Less:Non operating expense
-25.54%3.37M
6,746.51%3.6M
-80.61%39.05M
-35.90%25.18M
376.06%4.53M
-93.75%52.53K
171.96%201.34M
44.57%39.28M
-90.81%950.9K
-91.61%839.93K
Total profit
43.66%278.76M
1.78%116.43M
-7.09%488.17M
45.59%303.64M
21.51%194.05M
33.09%114.4M
337.27%525.44M
276.18%208.57M
98.24%159.7M
62.07%85.96M
Less:Income tax cost
127.28%111.86M
37.75%56.65M
-33.33%112.19M
-3.85%69.17M
20.38%49.22M
207.79%41.13M
580.72%168.28M
170.76%71.94M
131.72%40.88M
-4.46%13.36M
Net profit
15.24%166.89M
-18.41%59.78M
5.27%375.98M
71.62%234.47M
21.90%144.83M
0.94%73.27M
274.22%357.16M
373.20%136.63M
88.85%118.81M
85.90%72.59M
Net profit from continuing operation
15.24%166.89M
-18.41%59.78M
5.27%375.98M
71.62%234.47M
21.90%144.83M
0.94%73.27M
274.22%357.16M
373.20%136.63M
88.85%118.81M
85.90%72.59M
Less:Minority Profit
1.43%10.09M
-33.40%2.15M
153.76%17.52M
73.10%14.69M
59.80%9.94M
-24.36%3.22M
292.55%6.9M
151.46%8.49M
146.05%6.22M
1,056.80%4.26M
Net profit of parent company owners
16.25%156.81M
-17.72%57.63M
2.34%358.46M
71.52%219.78M
19.80%134.89M
2.51%70.05M
253.69%350.25M
402.55%128.14M
86.46%112.59M
76.65%68.33M
Earning per share
Basic earning per share
17.02%0.11
-18.37%0.04
0.00%0.25
63.15%0.1532
12.57%0.094
-3.92%0.049
257.14%0.25
396.83%0.0939
85.56%0.0835
75.86%0.051
Diluted earning per share
17.02%0.11
-18.37%0.04
0.00%0.25
63.15%0.1532
12.57%0.094
-3.92%0.049
257.14%0.25
396.83%0.0939
85.56%0.0835
75.86%0.051
Other composite income
-85.24%238.72K
135.84%66.13K
-69.04%921.94K
-63.85%1.42M
-11.33%1.62M
-42.26%-184.5K
619.62%2.98M
3,657.81%3.92M
971.61%1.82M
-200.73%-129.69K
Other composite income of parent company owners
-85.18%239.91K
134.51%66.47K
-69.13%919.41K
-63.98%1.42M
-11.62%1.62M
-46.92%-192.64K
619.62%2.98M
3,636.47%3.94M
968.07%1.83M
-200.87%-131.12K
Other composite income of minority owners
8.59%-1.19K
-104.23%-344.1
--2.53K
99.44%-77.36
82.84%-1.3K
470.47%8.14K
----
-1,403.55%-13.73K
-539.81%-7.6K
215.30%1.43K
Total composite income
14.13%167.13M
-18.12%59.85M
4.66%376.9M
67.83%235.89M
21.39%146.45M
0.86%73.09M
279.62%360.13M
388.65%140.55M
92.39%120.64M
84.96%72.46M
Total composite income of parent company owners
15.05%157.05M
-17.40%57.7M
1.74%359.38M
67.48%221.2M
19.30%136.5M
2.43%69.86M
258.78%353.23M
420.26%132.07M
90.16%114.42M
75.72%68.2M
Total composite income of minority owners
1.43%10.08M
-33.58%2.15M
153.80%17.52M
73.38%14.69M
59.97%9.94M
-24.19%3.23M
292.55%6.9M
150.98%8.47M
145.59%6.21M
1,061.09%4.26M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue -7.50%4.17B-17.58%1.94B-6.42%8.24B-2.52%6.4B1.95%4.51B0.02%2.35B8.15%8.81B7.60%6.57B10.23%4.42B16.49%2.35B
Operating revenue -7.50%4.17B-17.58%1.94B-6.42%8.24B-2.52%6.4B1.95%4.51B0.02%2.35B8.15%8.81B7.60%6.57B10.23%4.42B16.49%2.35B
Other operating revenue -43.47%16.59M-----34.58%58.56M----7.31%29.36M-----9.32%89.5M-----33.83%27.36M----
Total operating cost -8.67%3.88B-18.64%1.82B-9.14%7.66B-3.92%6.03B0.95%4.25B-0.78%2.24B5.83%8.44B4.09%6.27B7.69%4.21B15.47%2.25B
Operating cost 4.69%2.69B-9.10%1.2B-9.06%4.89B-6.16%3.78B-5.23%2.57B-8.33%1.32B9.10%5.38B8.49%4.03B12.68%2.71B20.38%1.44B
Operating tax surcharges -17.44%35.59M-19.35%17.67M-1.66%81.75M0.64%61.88M4.34%43.1M6.72%21.91M-0.88%83.13M-5.84%61.49M-1.86%41.31M-4.39%20.53M
Operating expense -34.77%723.18M-33.89%386.75M-11.76%1.81B-0.72%1.48B12.38%1.11B9.82%585.04M1.72%2.05B-0.10%1.49B-0.42%986.54M7.30%532.71M
Administration expense -24.86%422.33M-33.67%204.15M7.92%815.55M11.19%708.52M28.90%562.04M32.06%307.76M1.75%755.71M1.13%637.2M11.22%436.03M12.62%233.05M
Financial expense 55.98%-25.48M46.68%-5.84M-478.84%-29.97M-774.81%-50.08M-1,152.19%-57.9M-263.89%-10.95M-93.13%7.91M-106.54%-5.72M-108.03%-4.62M-66.07%6.68M
-Interest expense (Financial expense) -10.79%35.97M-8.57%17.9M-15.98%77.39M-16.81%56.7M-8.77%40.32M-12.66%19.57M-23.34%92.11M-23.75%68.15M-27.59%44.2M-17.96%22.41M
-Interest Income (Financial expense) 23.53%-77.18M32.17%-25.69M-65.18%-155.08M-82.97%-123.52M-130.11%-100.93M-91.35%-37.87M-67.88%-93.88M-142.07%-67.51M-125.08%-43.86M-103.05%-19.79M
Research and development 44.02%35.98M34.34%17.04M-39.50%97.04M-25.31%42.26M-36.95%24.98M-40.05%12.68M92.18%160.39M66.37%56.58M87.90%39.63M86.29%21.15M
Credit Impairment Loss -413.52%-2.98M138.62%257.5K132.47%6.79M137.78%2.96M109.95%952.08K83.26%-666.68K-31.24%-20.9M-453.54%-7.84M-440.53%-9.57M-109.24%-3.98M
Asset Impairment Loss 47.46%-66.27M-11.76%-37.67M-30.54%-193.49M-27.15%-138.66M-57.42%-126.12M-22.91%-33.7M-55.39%-148.23M-142.15%-109.06M-108.92%-80.11M-92.94%-27.42M
Other net revenue 88.28%-7.56M68.83%-3.51M-124.99%-80.67M8.14%-64.72M-0.41%-64.47M26.56%-11.26M2,437.36%322.84M-4,935.75%-70.46M-500.50%-64.21M-150.28%-15.33M
Invest income -61.52%2.93M--2.27M--8.61M--8.29M--7.62M----------0--------
Asset deal income -96.17%6.65K-90.86%6.65K-99.96%172.21K500.58%172.91K328.89%173.92K79.48%72.78K12,641.67%419.3M-101.96%-43.16K1,263.60%40.55K1,279.75%40.55K
Other revenue 11.08%58.75M37.26%31.62M33.84%97.26M34.49%62.51M107.98%52.9M43.71%23.04M9.40%72.67M18.51%46.48M2.38%25.43M60.52%16.03M
Operating profit 46.05%278.3M10.06%117.67M-28.45%498.23M37.80%313.74M31.77%190.56M26.22%106.92M271.69%696.36M188.73%227.67M63.51%144.61M35.43%84.71M
Add:Non operating Income -52.26%3.83M-68.65%2.36M-4.71%28.99M-25.24%15.09M-50.02%8.02M260.63%7.54M344.36%30.43M436.46%20.18M551.38%16.04M317.60%2.09M
Less:Non operating expense -25.54%3.37M6,746.51%3.6M-80.61%39.05M-35.90%25.18M376.06%4.53M-93.75%52.53K171.96%201.34M44.57%39.28M-90.81%950.9K-91.61%839.93K
Total profit 43.66%278.76M1.78%116.43M-7.09%488.17M45.59%303.64M21.51%194.05M33.09%114.4M337.27%525.44M276.18%208.57M98.24%159.7M62.07%85.96M
Less:Income tax cost 127.28%111.86M37.75%56.65M-33.33%112.19M-3.85%69.17M20.38%49.22M207.79%41.13M580.72%168.28M170.76%71.94M131.72%40.88M-4.46%13.36M
Net profit 15.24%166.89M-18.41%59.78M5.27%375.98M71.62%234.47M21.90%144.83M0.94%73.27M274.22%357.16M373.20%136.63M88.85%118.81M85.90%72.59M
Net profit from continuing operation 15.24%166.89M-18.41%59.78M5.27%375.98M71.62%234.47M21.90%144.83M0.94%73.27M274.22%357.16M373.20%136.63M88.85%118.81M85.90%72.59M
Less:Minority Profit 1.43%10.09M-33.40%2.15M153.76%17.52M73.10%14.69M59.80%9.94M-24.36%3.22M292.55%6.9M151.46%8.49M146.05%6.22M1,056.80%4.26M
Net profit of parent company owners 16.25%156.81M-17.72%57.63M2.34%358.46M71.52%219.78M19.80%134.89M2.51%70.05M253.69%350.25M402.55%128.14M86.46%112.59M76.65%68.33M
Earning per share
Basic earning per share 17.02%0.11-18.37%0.040.00%0.2563.15%0.153212.57%0.094-3.92%0.049257.14%0.25396.83%0.093985.56%0.083575.86%0.051
Diluted earning per share 17.02%0.11-18.37%0.040.00%0.2563.15%0.153212.57%0.094-3.92%0.049257.14%0.25396.83%0.093985.56%0.083575.86%0.051
Other composite income -85.24%238.72K135.84%66.13K-69.04%921.94K-63.85%1.42M-11.33%1.62M-42.26%-184.5K619.62%2.98M3,657.81%3.92M971.61%1.82M-200.73%-129.69K
Other composite income of parent company owners -85.18%239.91K134.51%66.47K-69.13%919.41K-63.98%1.42M-11.62%1.62M-46.92%-192.64K619.62%2.98M3,636.47%3.94M968.07%1.83M-200.87%-131.12K
Other composite income of minority owners 8.59%-1.19K-104.23%-344.1--2.53K99.44%-77.3682.84%-1.3K470.47%8.14K-----1,403.55%-13.73K-539.81%-7.6K215.30%1.43K
Total composite income 14.13%167.13M-18.12%59.85M4.66%376.9M67.83%235.89M21.39%146.45M0.86%73.09M279.62%360.13M388.65%140.55M92.39%120.64M84.96%72.46M
Total composite income of parent company owners 15.05%157.05M-17.40%57.7M1.74%359.38M67.48%221.2M19.30%136.5M2.43%69.86M258.78%353.23M420.26%132.07M90.16%114.42M75.72%68.2M
Total composite income of minority owners 1.43%10.08M-33.58%2.15M153.80%17.52M73.38%14.69M59.97%9.94M-24.19%3.23M292.55%6.9M150.98%8.47M145.59%6.21M1,061.09%4.26M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Grant Tung Certified Public Accountants (Special General Partnership)------Grant Tung Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data